News Today Channel - The FDA has approved Baqsimi, a nasally administered glucagon, for treatment of severe hypoglycemia in people with diabetes four years & older. It is administered like a nasal
SOYEZ PRÊT EN CAS DE SITUATION D'URGENCE DUE À UNE HYPOGLYCÉMIE SÉVÈRE (TAUX TRÈS BAS DE SUCRE DANS LE SANG)
![FDA Approves First Treatment for Severe Hypoglycemia That Can Be Administered without an Injection - Endocrine News FDA Approves First Treatment for Severe Hypoglycemia That Can Be Administered without an Injection - Endocrine News](https://endocrinenews.endocrine.org/wp-content/uploads/BAQSIMI-Product-Photo-Final.jpg)